The total number of hilar neurons per hippocampus computed

in the present study (39.200 ± 3.882) compares closely to the number reported by Jiao and Nadler (2007) (37.580 ± 1.594), Buckmaster and Dudek (1997) (41.093 ± 1.284), who used essentially the same optical disector approach, and by Miki et al., 2005 (35.200 ± 1.600), who used a physical disector approach. The similarity of our results with previously reported values demonstrates high precision in the stereological estimates of neuronal number. Previous studies on pilocarpine model showed that cell death occurs by necrosis or apoptosis (Fujikawa, 1996, Fujikawa, 2005, Fujikawa et al., 2000, Fujikawa et al., 2002, Fujikawa et al., 2007 and Henshall, 2007). In contrast to acute cell death, which occurs in the first 24–48 h and is predominantly necrotic, secondary or delayed neuronal cell death occurring XAV-939 mw at later stages has been identified to be predominantly

apoptotic (Kermer and Klocker, 1999, Snider et al., 1999 and Weise et al., 2005). Caspases are considered the common apoptosis execution pathway, and its activation raises structural alterations that characterize apoptosis (Henkart and Gristein, 1996). In the present investigation, we evaluated two types of caspases: caspase-1, related with inflammatory process, and caspase-3, which executes the apoptosis (Earnshaw et al., 1999 and Henkart and Gristein, 1996). As previously demonstrated in the pilocarpine model (Persike et al., 2008) we also observed Vorinostat solubility dmso an increased activity of caspases-1 and -3 seven days after SE. Treatment with Pyr and/or

Oxa did not prevent the increase of caspases activation, but it was significantly less pronounced (only for caspase-1) when rats were treated with Oxa or Pyr + Oxa. This result suggests that early Glu scavenging did not prevent late apoptotic neuronal cell death. In fact, Weise else et al. (2005) observed that significant neuronal cell loss occurred in brain regions that showed activated caspase-3 expression. Areas with the highest levels of activated caspase-3 expression displayed the most extensive neuronal cell loss (Weise et al., 2005). In the present work, the increase of caspase-3 activity was not modified by Pyr and/or Oxa administration 30 min after SE. Nevertheless, it remains to be determined if late or prolonged Glu scavenging prevents SE-induced caspase activation and late neuronal cell loss. Blood glutamate scavenging has been demonstrated to be neuroprotective in terms of neurological outcome. Zlotnik and colleagues tested the hypothesis that Pyr- or Oxa-mediated blood Glu scavenging causes neuroprotection in a rat model of closed head injury (CHI), in which there is a well established deleterious increase of Glu in brain fluids.